Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,969 | -78,537 | -57,982 | -34,640 | -16,978 |
| Depreciation Amortization | -297 | -1,133 | -490 | -490 | -123 |
| Accounts payable and accrued liabilities | -1,868 | -2,349 | -1,785 | -509 | -684 |
| Other Working Capital | -4,305 | 9,120 | 5,285 | -878 | -1,000 |
| Other Operating Activity | 3,868 | 8,408 | 6,402 | 3,497 | 2,364 |
| Operating Cash Flow | $-25,571 | $-64,491 | $-48,570 | $-33,020 | $-16,421 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 22,461 | -1,634 | 55,504 | 35,866 | 18,123 |
| PPE Investments | -6 | -7 | N/A | N/A | N/A |
| Investing Cash Flow | $22,455 | $-1,641 | $55,504 | $35,866 | $18,123 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 77,426 | 2,851 | N/A | N/A |
| Financing Cash Flow | $N/A | $77,426 | $2,851 | $N/A | $N/A |
| Beginning Cash Position | 29,162 | 17,868 | 17,868 | 17,868 | 17,868 |
| End Cash Position | 26,046 | 29,162 | 27,653 | 20,714 | 19,570 |
| Net Cash Flow | $-3,116 | $11,294 | $9,785 | $2,846 | $1,702 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,571 | -64,491 | -48,570 | -33,020 | -16,421 |
| Capital Expenditure | -6 | -7 | N/A | N/A | N/A |
| Free Cash Flow | -25,577 | -64,498 | -48,570 | -33,020 | -16,421 |